PolyPid (PYPD) News Today

→ AI “wealth window” is closing soon! (From Paradigm Press) (Ad)

$4.30

-0.14 (-3.15%)

(As of 04/18/2024 ET)

Source

Source	Headline
	PolyPid Ltd. (PYPD) Stock Historical Prices & Data - Yahoo Finance finance.yahoo.com - April 18 at 12:39 PM
	Short Interest in PolyPid Ltd. (NASDAQ:PYPD) Declines By 17.5% americanbankingnews.com - April 15 at 5:58 AM
	PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference globenewswire.com - February 28 at 7:00 AM
	PolyPid Ltd. (PYPD) Upgraded to Buy: What Does It Mean for the Stock? finance.yahoo.com - February 19 at 6:10 PM
	PolyPid Ltd. (NASDAQ:PYPD) Q4 2023 Earnings Call Transcript finance.yahoo.com - February 15 at 11:57 AM
	Buy Rating for PolyPid Amid Positive D-PLEX100 Trial Prospects and Strategic Market Positioning markets.businessinsider.com - February 14 at 5:44 PM
	PolyPid Ltd.: PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results finanznachrichten.de - February 14 at 12:44 PM
	PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results finance.yahoo.com - February 14 at 7:32 AM
	PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results globenewswire.com - February 14 at 7:00 AM
	PolyPid Ltd.: PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial finanznachrichten.de - February 12 at 7:54 AM
	PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial finance.yahoo.com - February 12 at 7:54 AM
	PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024 finance.yahoo.com - January 31 at 10:35 AM
	Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session msn.com - January 5 at 3:33 PM
	Cyclacel Pharmaceuticals, Angiodynamic among healthcare movers msn.com - January 5 at 10:29 AM
	PolyPid Ltd. (PYPD) uk.finance.yahoo.com - January 4 at 6:14 PM
	PolyPid looks to raise $16.2M through private placement msn.com - January 4 at 6:14 PM
	PolyPid Announces Private Placement for $16 Million in Gross Proceeds finance.yahoo.com - January 4 at 6:14 PM
	marketbeat.com - January 2 at 11:12 AM
	PolyPid Ltd. (NASDAQ:PYPD) Q3 2023 Earnings Call Transcript finance.yahoo.com - November 12 at 1:15 PM
	Earnings call: PolyPid's Q3 2023 financial results show decreased expenses and progress in SHIELD II trial investing.com - November 12 at 8:15 AM
	PolyPid Provides Corporate Update and Reports Third Quarter 2023 Financial Results finance.yahoo.com - November 8 at 8:16 AM
	PolyPid's Earnings: A Preview benzinga.com - November 7 at 5:14 PM
	PolyPid Announces the Addition of Dr. Nurit Tweezer-Zaks to its Board of Directors finance.yahoo.com - November 7 at 7:12 AM
	PolyPid to Report Third Quarter 2023 Financial Results and Operational Highlights on November 8, 2023 finance.yahoo.com - November 1 at 9:30 AM
	Barclays Maintains Polypid (PYPD) Equal-Weight Recommendation msn.com - October 24 at 10:11 PM
	PolyPid Regains Compliance with Nasdaq Minimum Closing Bid Price Rule finance.yahoo.com - October 19 at 10:59 AM
	HC Wainwright & Co. Initiates Coverage of Polypid (PYPD) with Buy Recommendation msn.com - October 13 at 2:17 PM
	Promising Clinical Trials and Innovative PLEX Technology Drive Analyst’s Buy Rating for PolyPid Ltd. markets.businessinsider.com - October 12 at 9:29 AM
	Resilient PolyPid Maintains Buy Rating Despite Challenges: An Analysis of Ongoing Trials and Financial Adjustments markets.businessinsider.com - October 9 at 2:04 PM
	PolyPid Announces Presentation at the American College of Surgeons Clinical Congress 2023 finance.yahoo.com - October 9 at 9:03 AM
	Polypid (PYPD) Price Target Increased by 2900.00% to 68.85 msn.com - October 5 at 9:05 AM
	PolyPid Announces Publication of Preclinical Data Further Supporting the Good Safety Profile of D-PLEX₁₀₀ and PLEX Technology Platform finance.yahoo.com - October 4 at 8:12 AM
	PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference finance.yahoo.com - September 22 at 10:07 AM
	marketbeat.com - September 22 at 9:46 AM
	marketbeat.com - September 21 at 11:32 AM
	PolyPid Announces Successful Commercial Good Manufacturing Practice (GMP) Audit by Israeli Ministry of Health finance.yahoo.com - September 21 at 8:17 AM
	PolyPid Announces Reverse Share Split finance.yahoo.com - September 20 at 10:31 AM
	PolyPid Completes Manufacturing-Process Validation for D-PLEX marketwatch.com - September 19 at 1:13 PM
	PolyPid Announces Successful Completion of Manufacturing Process Validation for D-PLEX₁₀₀ finance.yahoo.com - September 19 at 8:12 AM
	JMP Securities Keeps Their Buy Rating on PolyPid (PYPD) markets.businessinsider.com - August 10 at 10:23 AM
	PolyPid Ltd.: PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results finanznachrichten.de - August 9 at 8:32 AM
	PolyPid GAAP EPS of -$0.36 msn.com - August 9 at 8:32 AM
	PolyPid Provides Corporate Update and Reports Second Quarter 2023 Financial Results finance.yahoo.com - August 9 at 8:32 AM
	Polypid (PYPD) Price Target Decreased by 20.59% to 2.30 msn.com - August 3 at 7:30 PM
	PolyPid to Report Second Quarter 2023 Financial Results and Operational Highlights on August 9, 2023 finance.yahoo.com - July 26 at 11:11 PM
	PolyPid Announces New Publication Highlighting Potent Antibacterial Activity of D-PLEX₁₀₀ against Susceptible and Resistant Bacteria for the Prevention of Surgical Site Infections finance.yahoo.com - June 29 at 1:15 PM
	PolyPid Announces Recruitment of First Patient in Revised SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections finance.yahoo.com - June 22 at 9:07 AM
	PolyPid Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Requirement and Transfer of its Listing to the Nasdaq Capital Market finance.yahoo.com - June 5 at 6:51 PM
	PolyPid Announces FDA Agreement on the Design of SHIELD II Phase 3 Trial Evaluating D-PLEX₁₀₀ for Prevention of Abdominal Colorectal Surgical Site Infections finance.yahoo.com - May 22 at 12:50 PM
	PolyPid Ltd. (NASDAQ:PYPD) Q1 2023 Earnings Call Transcript finance.yahoo.com - May 13 at 5:37 PM

Get PolyPid News Delivered to You Automatically

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

PYPD Media Mentions By Week

PYPD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PYPD
News Sentiment
▼
0.98

0.53
▲
Average
Medical
News Sentiment

PYPD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PYPD Articles
This Week
▼
2

1
▲
PYPD Articles
Average Week

Get PolyPid News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:PYPD) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

PolyPid (PYPD) News Today

PYPD Media Mentions By Week

PYPD Media Sentiment

PYPD News Coverage

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info